Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient

Cell Transplantation

Volumn 21, Issue 7, 2012, Pages 1547-1559

  Paulsen, Bruna da Silveira ^a   Maciel, Renata de Moraes ^a   Galina, Antonio ^a   da Silveira, Mariana Souza ^a   Souza, Cleide dos Santos ^a   Drummond, Hannah ^a   Pozzatto, Ernesto Nascimento ^a   Junior, Hamilton Silva ^a   Chicaybam, Leonardo ^b   Massuda, Raffael ^c   Setti Perdigão, Pedro ^a   Bonamino, Martin ^b   Belmonte de Abreu, Paulo Silva ^c   Castro, Newton Gonçalves ^c   Brentani, Helena ^d   Rehen, Stevens Kastrup ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Induced pluripotent stem cells; Oxygen metabolism; Reactive oxygen species (ROS) production; Schizophrenia

Indexed keywords

AMINO ACID DECARBOXYLASE; BETA TUBULIN; CHOLINE ACETYLTRANSFERASE; DOPAMINE TRANSPORTER; OXYGEN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR LHX3; VALPROIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; ENDODERM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; MITOCHONDRION; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROECTODERM; OXYGEN CONSUMPTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATION CONTROL; RESPIRATORY CHAIN; SCHIZOPHRENIA; SKIN FIBROBLAST;

EID: 84868582029     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X600957     Document Type: Article

References (54)

1. Abramov, A. Y.; Scorziello, A.; Duchen, M. R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 27(5):1129-1138; 2007.
2. Bachmann, R. F.; Wang, Y.; Yuan, P.; Zhou, R.; Li, X.; Alesci, S.; Du, J.; Manji, H. K. Common effects of lithium and valproate on mitochondrial functions: Protection against methamphetamine-induced mitochondrial damage. Int. J. Neuropsychopharmacol. 12(6):805-822; 2009.
3. Baharvand, H.; Mehrjardi, N. Z.; Hatami, M.; Kiani, S.; Rao, M.; Haghighi, M. M. Neural differentiation from human embryonic stem cells in a defined adherent culture condition. Int. J. Dev. Biol. 51(5):371-378; 2007.
4. Beltrao-Braga, P. I.; Pignatari, G. C.; Maiorka, P. C.; Oliveira, N. A.; Lizier, N. F.; Wenceslau, C. V.; Miglino, M. A.; Muotri, A. R.; Kerkis, I. Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells. Cell Transplant. 20(11-12):1707-1719; 2011.
5. Ben-Shachar, D. Mitochondrial dysfunction in schizophrenia: A possible linkage to dopamine. J. Neurochem. 83(6): 1241-1251; 2002.
6. Bitanihirwe, B. K. Y.; Woo, T. U. W. Oxidative stress in schizophrenia: An integrated approach. Neurosci. Biobehav. Rev. 35(3):878-893; 2011.
7. Brennand, K. J.; Simone, A.; Jou, J.; Gelboin-Burkhart, C.; Tran, N.; Sangar, S.; Li, Y.; Mu, Y.; Chen, G.; Yu, D.; McCarthy, S.; Sebat, J.; Gage, F. H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-225; 2011.
8. Chen, C. T.; Hsu, S. H.; Wei, Y. H. Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. Biochim. Biophys. Acta 1800(3): 257-263; 2010.
9. Chen, C. T.; Shih, Y. R. V.; Kuo, T. K.; Lee, O. K.; Wei, Y. H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26(4):960-968; 2008.
10. Chiang, C. H.; Su, Y.; Wen, Z.; Yoritomo, N.; Ross, C. A.; Margolis, R. L.; Song, H.; Ming, G. L. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16(4): 358-360; 2011.
11. Clay, H. B.; Sillivan, S.; Konradi, C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29(3):311-324; 2011.
12. da-Silva, W. S.; Gomez-Puyou, A.; de Gomez-Puyou, M. T.; Moreno-Sanchez, R.; De Felice, F. G.; de Meis, L.; Oliveira, M. F.; Galina, A. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: Steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J. Biol. Chem. 279(38):39846-39855; 2004.
13. Dimos, J. T.; Rodolfa, K. T.; Niakan, K. K.; Weisenthal, L. M.; Mitsumoto, H.; Chung, W.; Croft, G. F.; Saphier, G.; Leibel, R.; Goland, R.; Wichterle, H.; Henderson, C. E.; Eggan, K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321(5893):1218-1221; 2008.
14. Do, K. Q.; Cabungcal, J. H.; Frank, A.; Steullet, P.; Cuenod, M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 19(2):220-230; 2009.
15. Ebert, A. D.; Yu, J.; Rose, Jr., F. F.; Mattis, V. B.; Lorson, C. L.; Thomson, J. A.; Svendsen, C. N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227):277-280; 2009.
16. Ellis, J.; Bruneau, B. G.; Keller, G.; Lemischka, I. R.; Nagy, A.; Rossant, J.; Srivastava, D.; Zandstra, P. W.; Stanford, W. L. Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell 4(3):198-199; 2009.
17. Esteban, M. A.; Wang, T.; Qin, B.; Yang, J.; Qin, D.; Cai, J.; Li, W.; Weng, Z.; Chen, J.; Ni, S.; Chen, K.; Li, Y.; Liu, X.; Xu, J.; Zhang, S.; Li, F.; He, W.; Labuda, K.; Song, Y.; Peterbauer, A.; Wolbank, S.; Redl, H.; Zhong, M.; Cai, D.; Zeng, L.; Pei, D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6(1):71-79; 2010.
18. Ezashi, T.; Das, P.; Roberts, R. M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. USA 102(13):4783-4788; 2005.
19. Fernandes, A. M.; Meletti, T.; Guimaraes, R.; Stelling, M. P.; Marinho, P. A.; Valladao, A. S.; Rehen, S. K. Worldwide survey of published procedures to culture human embryonic stem cells. Cell Transplant. 19(5):509-523; 2010.
20. Giasson, B. I.; Ischiropoulos, H.; Lee, V. M. Y.; Trojanowski, J. Q. The relationship between oxidative/ nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic. Biol. Med. 32(12): 1264-1275; 2002.
21. Golse, B.; Debray, Q.; Puget, K.; Michelson, A. M. Superoxide dismutase 1 and glutathione peroxidase levels in erythrocytes of adult schizophrenics. Nouv. Presse Med. 7(23):2070-2071; 1978.
22. Gysin, R.; Kraftsik, R.; Sandell, J.; Bovet, P.; Chappuis, C.; Conus, P.; Deppen, P.; Preisig, M.; Ruiz, V.; Steullet, P.; Tosig, M.; Werge, T.; Cuenod, M.; Do, K. Q. Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proc. Natl. Acad. Sci. USA 104(42):16621-16626; 2007.
23. Ha, J. S.; Lee, J. E.; Lee, J. R.; Lee, C. S.; Maeng, J. S.; Bae, Y. S.; Kwon, K. S.; Park, S. S. Nox4-dependent H2O2 production contributes to chronic glutamate toxicity in primary cortical neurons. Exp. Cell Res. 316(10):1651-1661; 2010.
24. Haller, T.; Ortner, M.; Gnaiger, E. A respirometer for investigating oxidative cell metabolism: Toward optimization of respiratory studies. Anal. Biochem. 218(2):338-342; 1994.
25. Halliwell, B.; Gutteridge, J. M. C. Free radicals in biology and medicine, 4th ed. Oxford/New York: Oxford University Press; 2007.
26. Hutter, E.; Renner, K.; Pfister, G.; Stockl, P.; Jansen-Dürr, P.; Gnaiger, E. Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem. J. 380(Pt 3):919-928; 2004.
27. Insel, T. R. Rethinking schizophrenia. Nature 468(7321): 187-193; 2010.
28. Keilin, D. Cytochrome and respiratory enzymes. Proc. R. Soc. Lond. Ser. B 104:206-252; 1929.
29. Lai, J. S.; Zhao, C.; Warsh, J. J.; Li, P. P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539(1-2):18-26; 2006.
30. Le Belle, J. E.; Orozco, N. M.; Paucar, A. A.; Saxe, J. P.; Mottahedeh, J.; Pyle, A. D.; Wu, H.; Kornblum, H. I. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 8(1):59-71; 2011.
31. Lewis, D. A.; Lieberman, J. A. Catching up on schizophrenia: Natural history and neurobiology. Neuron 28(2): 325-334; 2000.
32. Liu, S. P.; Fu, R. H.; Huang, Y. C.; Chen, S. Y.; Chien, Y. J.; Hsu, C. Y.; Tsai, C. H.; Shyu, W. C.; Lin, S. Z. Induced pluripotent stem (iPS) cell research overview. Cell Transplant. 20(1):15-19; 2011.
33. Lowry, W. E.; Richter, L.; Yachechko, R.; Pyle, A. D.; Tchieu, J.; Sridharan, R.; Clark, A. T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105(8):2883-2888; 2008.
34. Marchetto, M. C. N.; Carromeu, C.; Acab, A.; Yu, D.; Yeo, G. W.; Mu, Y.; Chen, G.; Gage, F. H.; Muotri, A. R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143(4):527-539; 2010.
35. Marchetto, M. C. N.; Winner, B.; Gage, F. H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum. Mol. Genet. 19(R1):R71-76; 2010.
36. Matigian, N. A.; McCurdy, R. D.; Feron, F.; Perry, C.; Smith, H.; Filippich, C.; McLean, D.; McGrath, J.; Mackay-Sim, A.; Mowry, B.; Hayward, N. K. Fibroblast and lymphoblast gene expression profiles in schizophrenia: Are non-neural cells informative? PLoS One 3(6): e2412; 2008.
37. Meyer, L. E.; Machado, L. B.; Santiago, A. P. S. A.; da-Silva, W. S.; De Felice, F. G.; Holub, O.; Oliveira, M. F.; Galina, A. Mitochondrial creatine kinase activity prevents reactive oxygen species generation: Antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J. Biol. Chem. 281(49):37361-37371; 2006.
38. Multhaup, G.; Ruppert, T.; Schlicksupp, A.; Hesse, L.; Beher, D.; Masters, C. L.; Beyreuther, K. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol. 54(5):533-539; 1997.
39. Nguyen, H. N.; Byers, B.; Cord, B.; Shcheglovitov, A.; Byrne, J.; Gujar, P.; Kee, K.; Schule, B.; Dolmetsch, R. E.; Langston, W.; Palmer, T. D.; Pera, R. R. LRRK2 Mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8(3):267-280; 2011.
40. Nicholls, D. G.; Budd, S. L. Mitochondria and neuronal survival. Physiol. Rev. 80(1):315-360; 2000.
41. Paulsen, B. S.; Souza, C. S.; Chicaybam, L.; Bonamino, M. H.; Bahia, M.; Costa, S. L.; Borges, H. L.; Rehen, S. K. Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells. Stem Cells Dev. 20(10):1711-1721; 2011.
42. Peng, Y. J.; Nanduri, J.; Yuan, G.; Wang, N.; Deneris, E.; Pendyala, S.; Natarajan, V.; Kumar, G. K.; Prabhakar, N. R. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J. Neurosci. 29(15):4903-4910; 2009.
43. Piccoli, C.; Ria, R.; Scrima, R.; Cela, O.; D'Aprile, A.; Boffoli, D.; Falzetti, F.; Tabilio, A.; Capitanio, N. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J. Biol. Chem. 280(28):26467-26476; 2005.
44. Rodríguez-Santiago, B.; Brunet, A.; Sobrino, B.; Serra-Juhe, C.; Flores, R.; Armengol, L.; Vilella, E.; Gabau, E.; Guitart, M.; Guillamat, R.; Martorell, L.; Valero, J.; Gutierrez-Zotes, A.; Labad, A.; Carracedo, A.; Estivill, X.; Peírez-Jurado, L. Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia. Mol. Psychiatry 15(10):1023-1033; 2010.
45. Rosenberg, G. The mechanisms of action of valproate in neuropsychiatric disorders: Can we see the forest for the trees? Cell. Mol. Life Sci. 64:2090-2103; 2007.
46. Schloesser, R. J.; Huang, J.; Klein, P. S.; Manji, H. K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33(1):110-133; 2008.
47. Soucek, T.; Cumming, R.; Dargusch, R.; Maher, P.; Schubert, D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39(1):43-56; 2003.
48. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of plur-ipotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872; 2007.
49. Tosic, M.; Ott, J.; Barral, S.; Bovet, P.; Deppen, P.; Gheorghita, F.; Matthey, M. L.; Parnas, J.; Preisig, M.; Sagara, M.; Solida, A.; Timm, S.; Wang, A. G.; Werge, T.; Cueínod, M.; Do, K. Q. Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet. 79(3):586-592; 2006.
50. Varum, S.; Rodrigues, A. S.; Moura, M. B.; Momcilovic, O.; Easley, 4th, C. A.; Ramalho-Santos, J.; Van Houten, B.; Schatten, G. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. Plos One 6(6):e20914; 2011.
51. Wang, J. F.; Shao, L.; Sun, X.; Young, L. T. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J. Neurochem. 88(6):1477-1484; 2004.
52. Yamato, M.; Kudo, W.; Shiba, T.; Yamada, K. I.; Watanabe, T.; Utsumi, H. Determination of reactive oxygen species associated with the degeneration of dopaminergic neurons during dopamine metabolism. Free Radic. Res. 44(3):249-257; 2010.
53. Yang, S.; Wang, X.; Liu, J.; Liu, Z.; Huang, J. The applications of induced pluripotent stem (iPS) cells in drug development. Front. Biol. 6(1):52-57; 2011.
54. Zou, J.; Sweeney, C. L.; Chou, B. K.; Choi, U.; Pan, J.; Wang, H.; Dowey, S. N.; Cheng, L.; Malech, H. L. Oxidase deficient neutrophils from X-linked chronic granulomatous disease iPS cells: Functional correction by zinc finger nuclease mediated safe harbor targeting. Blood 117(21):5561-5572; 2011.